Melanin concentrating hormone receptor ligands (especially substituted tetrahydroisoquinoline analogues), capable of modulating MCH receptor activity, are provided. Such ligands may be used to modulate MCH binding to MCH receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of metabolic, feeding and sexual disorders in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such ligands for detecting MCH receptors (e.g., receptor localization studies).
[EN] MELANIN CONCENTRATING HORMONE RECEPTOR LIGANDS: SUBSTITUTED TETRAHYDROISOQUINOLINE ANALOGUES<br/>[FR] LIGANDS RECEPTEURS DE L'HORMONE DE CONCENTRATION DE LA MELANINE: ANALOGUES DE TETRAHYDRO-ISOQUINOLEINE SUBSTITUEE
申请人:NEUROGEN CORP
公开号:WO2005077903A3
公开(公告)日:2006-02-23
PERCHONOCK C. D.; LANTOS I.; FINKELSTEIN J. A.; HOLDEN K. G., J. ORG. CHEM., 1980, 45, NO 10, 1950-1953
作者:PERCHONOCK C. D.、 LANTOS I.、 FINKELSTEIN J. A.、 HOLDEN K. G.
DOI:——
日期:——
Facile synthesis of halo-substituted tetrahydroisoquinolines and tetrahydro-2-benzazepines via N-acetyl-1,2-dihydroisoquinolines
作者:Carl D. Perchonock、Ivan Lantos、Joseph A. Finkelstein、Kenneth G. Holden